web3Decrypt
Moderna Stock Doubles on Cancer Breakthrough: Here’s What It Means
August 19, 2026

A Phase 3 win against the standard of care sent the biotech's shares up 131% and left short sellers down $4.8 billion.
GN Media aggregates headlines — read the full story on Decrypt.
Read full story on Decrypt
